ATE459640T1 - Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide - Google Patents

Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide

Info

Publication number
ATE459640T1
ATE459640T1 AT03780221T AT03780221T ATE459640T1 AT E459640 T1 ATE459640 T1 AT E459640T1 AT 03780221 T AT03780221 T AT 03780221T AT 03780221 T AT03780221 T AT 03780221T AT E459640 T1 ATE459640 T1 AT E459640T1
Authority
AT
Austria
Prior art keywords
protein phosphatase
ppa2
subunits
polynucleotides encoding
peptides binding
Prior art date
Application number
AT03780221T
Other languages
English (en)
Inventor
Alphonse Garcia
Xavier Cayla
Angelita Rebollo
Frederic Dessauge
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE459640T1 publication Critical patent/ATE459640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03780221T 2002-10-16 2003-10-13 Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide ATE459640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002408207A CA2408207A1 (fr) 2002-10-16 2002-10-16 Peptides liant la proteine phosphatase 2a et polynucleotides les codant
PCT/FR2003/003018 WO2004035611A2 (fr) 2002-10-16 2003-10-13 Peptides liant la proteine phosphatase 2a et polynucleotides les codant

Publications (1)

Publication Number Publication Date
ATE459640T1 true ATE459640T1 (de) 2010-03-15

Family

ID=32097367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780221T ATE459640T1 (de) 2002-10-16 2003-10-13 Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide

Country Status (12)

Country Link
US (2) US7498306B2 (de)
EP (2) EP1565487B1 (de)
AT (1) ATE459640T1 (de)
AU (1) AU2003288320A1 (de)
CA (1) CA2408207A1 (de)
CY (1) CY1110650T1 (de)
DE (1) DE60331576D1 (de)
DK (1) DK1565487T3 (de)
ES (1) ES2342162T3 (de)
PT (1) PT1565487E (de)
SI (1) SI1565487T1 (de)
WO (1) WO2004035611A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666481B9 (de) 2003-12-26 2019-05-22 HAGIWARA, Masatoshi Verfahren zur Regulierung der Phosphorylierung von SR-Proteinen und Antiviruswirkstoffen mit einem SR-Proteinaktivitätsregler als Wirkstoff

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
US5789201A (en) * 1996-02-23 1998-08-04 Cocensys, Inc. Genes coding for bcl-y a bcl-2 homologue
US5821082A (en) * 1996-05-23 1998-10-13 St. Louis University Health Sciences Center Anti-proliferation domain of a human Bcl-2 and DNA encoding the same
JP2000515504A (ja) * 1996-07-05 2000-11-21 フィリップ イー． ブラントン 細胞死を誘導するアデノウイルスｅ４蛋白質
AU5959200A (en) 1999-07-12 2001-01-30 Mcgill University E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
AU784561B2 (en) * 2000-06-23 2006-05-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Positively-charged peptide nucleic acid analogs with improved properties
WO2002072601A2 (en) * 2001-02-07 2002-09-19 The Burnham Institute Apoptosis modulator bcl-b and methods for making and using same
FR2827866B1 (fr) * 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations

Also Published As

Publication number Publication date
DK1565487T3 (da) 2010-06-21
EP1565487A2 (de) 2005-08-24
ES2342162T3 (es) 2010-07-02
US7498306B2 (en) 2009-03-03
PT1565487E (pt) 2010-06-08
SI1565487T1 (sl) 2010-07-30
CY1110650T1 (el) 2015-06-10
WO2004035611A3 (fr) 2005-06-30
WO2004035611A8 (fr) 2004-07-08
EP1565487B1 (de) 2010-03-03
AU2003288320A1 (en) 2004-05-04
US20100009909A1 (en) 2010-01-14
DE60331576D1 (de) 2010-04-15
CA2408207A1 (fr) 2004-04-16
HK1083850A1 (zh) 2006-07-14
WO2004035611A2 (fr) 2004-04-29
AU2003288320A8 (en) 2004-05-04
EP2243787A3 (de) 2011-05-18
EP2243787A2 (de) 2010-10-27
US20070065410A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
MX2022011411A (es) Proteinas de union a antigeno que se unen especificamente a mage-a.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
PE20251185A1 (es) Proteinas de union condicionalmente activadas restringidas
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
RU2009128979A (ru) Hla*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция
AR047729A1 (es) Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe)
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
BG101077A (bg) Пептиди
JP2019509037A5 (de)
EA201200515A1 (ru) Полипептиды и их применение
RU2008109015A (ru) Глипикан-3 (gpc3)-производные антигенные пептиды, отторгающие опухоли, используемые для нla-a2-положительных пациентов, и фармацевтическая продукция, включающая их
AR055179A1 (es) Procedimiento para la amidacion de polipeptidos con aminoacidos de caracter basico c-terminales mediante el uso de endoproteasas especificas
WO2020185796A9 (en) High avidity wt1 t cell receptors and uses thereof
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
ATE308335T1 (de) Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese
JP2019038772A5 (de)
ATE459640T1 (de) Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide
DK0667781T3 (da) Peptidbaserede diagnostiske og terapeutiske midler til spondylarthropatier
ID27162A (id) Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1
DK1915617T3 (da) Fremgangsmåder og sammensætninger til identifikation af et peptid, der har en intermolekylær interaktion med et interessemål
ATE213773T1 (de) In apoptosis beteiligte cysteine protease cmh-1 und dns-sequenzen dafür
Mullen et al. Synthesis and characterization of the 47‐residue heterodimeric antimicrobial peptide distinctin, featuring directed disulfide bridge formation
ATE338063T1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers
MX2025013106A (es) Anticuerpos dirigidos al complejo peptidico de catepsina g del antigeno leucocitario humano
DE50310131D1 (de) Peptide mit hohem cysteingehalt

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565487

Country of ref document: EP